VEGF-induced BBB permeability is associated with an MMP-9 activity increase in cerebral ischemia: both effects decreased by Ang-1
- PMID: 15902195
- DOI: 10.1038/sj.jcbfm.9600148
VEGF-induced BBB permeability is associated with an MMP-9 activity increase in cerebral ischemia: both effects decreased by Ang-1
Abstract
After cerebral ischemia, angiogenesis, by supplying for the deficient perfusion, may be a beneficial process for limiting neuronal death and promoting tissue repair. In this study, we showed that the combination of Ang-1 and vascular endothelial growth factor (VEGF) provides a more adapted therapeutic strategy than the use of VEGF alone. Indeed, we showed on a focal ischemia model that an early administration of VEGF exacerbates ischemic damage, because of its effects on blood-brain barrier (BBB) permeability. In contrast, a coapplication of Ang-1 and VEGF leads to a significant reduction of the ischemic and edema volumes by 50% and 42%, respectively, in comparison with VEGF-treated mice. We proposed that Ang-1 blocks the BBB permeability effect of VEGF in association with a modulation of matrix metalloproteinase (MMP) activity. Indeed, we showed on both ischemic in vivo and BBB in vitro models that VEGF enhances BBB damage and MMP-9 activity and that Ang-1 counteracts both effects. However, we also showed a synergic angiogenic effect of Ang-1 and VEGF in the brain. Taken together, these results allow to propose that, in cerebral ischemia, the combination of Ang-1 and VEGF could be used early to promote the formation of mature neovessels without inducing side effects on BBB permeability.
Similar articles
-
Aggravation of hemorrhagic transformation by early intraarterial infusion of low-dose vascular endothelial growth factor after transient focal cerebral ischemia in rats.Brain Res. 2005 Jul 5;1049(1):95-103. doi: 10.1016/j.brainres.2005.05.011. Brain Res. 2005. PMID: 15935998
-
Angiopoietin modulation of vascular endothelial growth factor: Effects on retinal endothelial cell permeability.Cytokine. 2007 Nov;40(2):144-50. doi: 10.1016/j.cyto.2007.09.001. Epub 2007 Oct 23. Cytokine. 2007. PMID: 17959386
-
VEGF protects brain against focal ischemia without increasing blood--brain permeability when administered intracerebroventricularly.J Cereb Blood Flow Metab. 2005 Sep;25(9):1111-8. doi: 10.1038/sj.jcbfm.9600109. J Cereb Blood Flow Metab. 2005. PMID: 15829918
-
[Recent advance in experimental study of cerebral ischemia treated by vascular endothelial growth factor].Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2005 Feb;27(1):115-9. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2005. PMID: 15782506 Review. Chinese.
-
Angiopoietin-1 in the treatment of ischemia and sepsis.Shock. 2009 Apr;31(4):335-41. doi: 10.1097/SHK.0b013e3181862c63. Shock. 2009. PMID: 18791498 Review.
Cited by
-
Teriparatide: an innovative and promising strategy for protecting the blood-spinal cord barrier following spinal cord injury.Front Pharmacol. 2024 May 6;15:1386565. doi: 10.3389/fphar.2024.1386565. eCollection 2024. Front Pharmacol. 2024. PMID: 38770002 Free PMC article. Review.
-
Recent advances in tissue repair of the blood-brain barrier after stroke.J Tissue Eng. 2024 Jan 31;15:20417314241226551. doi: 10.1177/20417314241226551. eCollection 2024 Jan-Dec. J Tissue Eng. 2024. PMID: 38304736 Free PMC article. Review.
-
Therapeutic Potentials of MicroRNA-126 in Cerebral Ischemia.Mol Neurobiol. 2023 Apr;60(4):2062-2069. doi: 10.1007/s12035-022-03197-4. Epub 2023 Jan 4. Mol Neurobiol. 2023. PMID: 36596965 Review.
-
COVID-19 and cognitive impairment: neuroinvasive and blood‒brain barrier dysfunction.J Neuroinflammation. 2022 Sep 7;19(1):222. doi: 10.1186/s12974-022-02579-8. J Neuroinflammation. 2022. PMID: 36071466 Free PMC article. Review.
-
Network Pharmacology Experiments Show That Emodin Can Exert a Protective Effect on MCAO Rats by Regulating Hif-1α/VEGF-A Signaling.ACS Omega. 2022 Jun 16;7(26):22577-22593. doi: 10.1021/acsomega.2c01897. eCollection 2022 Jul 5. ACS Omega. 2022. PMID: 35811865 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous